AU2003292133A1 - Plasmodium falciparum virulence factor var o - Google Patents

Plasmodium falciparum virulence factor var o

Info

Publication number
AU2003292133A1
AU2003292133A1 AU2003292133A AU2003292133A AU2003292133A1 AU 2003292133 A1 AU2003292133 A1 AU 2003292133A1 AU 2003292133 A AU2003292133 A AU 2003292133A AU 2003292133 A AU2003292133 A AU 2003292133A AU 2003292133 A1 AU2003292133 A1 AU 2003292133A1
Authority
AU
Australia
Prior art keywords
plasmodium falciparum
virulence factor
var
factor var
virulence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292133A
Other versions
AU2003292133A8 (en
Inventor
Cyril Badaut
Graham Bentley
Sebastien Igonet
Anne Lavergne
Cecile Le Scanf
Odile Puijalon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU2003292133A1 publication Critical patent/AU2003292133A1/en
Publication of AU2003292133A8 publication Critical patent/AU2003292133A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003292133A 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o Abandoned AU2003292133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002409897A CA2409897A1 (en) 2002-10-25 2002-10-25 Plasmodium falciparum virulence factor var o
CA2,409,897 2002-10-25
PCT/EP2003/013341 WO2004037856A2 (en) 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o

Publications (2)

Publication Number Publication Date
AU2003292133A1 true AU2003292133A1 (en) 2004-05-13
AU2003292133A8 AU2003292133A8 (en) 2004-05-13

Family

ID=32111429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292133A Abandoned AU2003292133A1 (en) 2002-10-25 2003-10-24 Plasmodium falciparum virulence factor var o

Country Status (3)

Country Link
AU (1) AU2003292133A1 (en)
CA (1) CA2409897A1 (en)
WO (1) WO2004037856A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2783107C (en) * 2009-12-05 2018-08-07 Ann-Kristin Mueller Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5851296A (en) * 1995-04-27 1996-11-18 Affymax Technologies N.V. Malaria peptides and vaccines

Also Published As

Publication number Publication date
WO2004037856A2 (en) 2004-05-06
WO2004037856A3 (en) 2004-07-29
CA2409897A1 (en) 2004-04-25
AU2003292133A8 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003279836A1 (en) Exercise garment
AU2002349911A1 (en) Exercise
AU2003281505A1 (en) Chair
AU2003298032A1 (en) Cane base
AU2003203099A8 (en) Manually-propelled wheelchair
AU2003276227A1 (en) X-ray stand
AU2003246897A1 (en) Stairlift
AU2003212899A1 (en) Enhanced photodetector
AU2003292133A1 (en) Plasmodium falciparum virulence factor var o
AU2003265528A1 (en) Stand
AU2003277582A1 (en) Fluoropolymer
AU155791S (en) Stand
GB2387348B (en) Flat-folding stand
AU2003214263A1 (en) Showcase
AU2003230338A1 (en) Chair
AU2002100113A4 (en) Castor way
GB0219942D0 (en) Castor etc
AUPS198802A0 (en) Exerciser
AUPS320402A0 (en) Showcase
CA94404S (en) Climber
PL113030U1 (en) Showcase
CA94484S (en) Chair
AU2003212779A1 (en) Tea bath
AUPS111302A0 (en) Stand
GB0210530D0 (en) Wheelchair

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase